title: The impact of expression of the metastasis suppressor protein KAI1 on prognosis in invasive squamous cell cervical cancer.
abstract: OBJECTIVE
  Loss of KAI1 protein is a frequent event in various types of cancer and has been reported to be associated with increased rate of metastasis and shorter survival time.
  
  
  METHODS
  Expression of KAI1 and p53 was immunohistochemically determined in 75 biopsy specimens from patients with primary irradiated, invasive squamous cell cervical cancer and 30 cases with CIN I-III.
  
  
  RESULTS
  In invasive cancer, 22 cases showed strong expression, 42 cases down-regulation, and 11 cases no expression of KAI1. All specimens with CIN I showed strong KAI1 expression, while in CIN II and III down-regulation was observed in 45% of cases. There was no significant correlation of KAI1 expression with clinical and histopathological parameters. No influence of KAI1 expression on prognosis was observed.
  
  
  CONCLUSIONS
  KAI1-down-regulation is a frequent event in cervical cancer occurring early in carcinogenesis. KAI1 expression did not influence the prognosis of patients with primary irradiated cervical cancer.
authors.affiliation: Institute of Clinical Pathology, Department of Gynaecopathology and Cytology, University of Vienna, Austria.
authors.forename: M
authors.initials: M
authors.lastname: Schindl
authors.forename: P
authors.initials: P
authors.lastname: Birner
authors.forename: B
authors.initials: B
authors.lastname: Bachtiary
authors.forename: G
authors.initials: G
authors.lastname: Breitenecker
authors.forename: E
authors.initials: E
authors.lastname: Selzer
authors.forename: G
authors.initials: G
authors.lastname: Oberhuber
mesh_terms: D015703:Antigens, CD / Q000378:metabolism*; D002294:Carcinoma, Squamous Cell / Q000378:metabolism* / Q000473:pathology; D002584:Cervix Uteri / Q000378:metabolism; D018572:Disease-Free Survival; D015536:Down-Regulation; D005260:Female; D006801:Humans; D051861:Kangai-1 Protein; D008562:Membrane Glycoproteins / Q000378:metabolism*; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000378:metabolism*; D011379:Prognosis; D011518:Proto-Oncogene Proteins; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*; D002583:Uterine Cervical Neoplasms / Q000378:metabolism* / Q000473:pathology; D002578:Uterine Cervical Dysplasia / Q000378:metabolism* / Q000473:pathology
chemical_list: D015703:Antigens, CD; C497688:CD82 protein, human; D051861:Kangai-1 Protein; D008562:Membrane Glycoproteins; D009363:Neoplasm Proteins; D011518:Proto-Oncogene Proteins; D016159:Tumor Suppressor Protein p53